• <div id="y09gn"></div>
  • <li id="y09gn"></li>
    <dl id="y09gn"></dl>
    <div id="y09gn"><s id="y09gn"></s></div>
    来宝网Logo

    热门词:生物显微镜 水质分析仪 微波消解 荧光定量PCR 电化学工作站 生物安全柜

    现在位置首页>技术资料首页>行业动态>公司动态>Imagine Media收购DMI 生命科学

    Imagine Media收购DMI 生命科学

    Imagine Media2010年1月28日 13:17 点击:1714

    Imagine Media收购DMI 生命科学
    Imagine Media, Ltd. Signs Letter of Intent to Acquire DMI Life Sciences
    DENVER--(BUSINESS WIRE)--Imagine Media, Ltd., a Delaware corporation (“Imagine” or the “Company”) (OTCBB: IMLE) today announced that it has signed a non-binding Letter of Intent to acquire DMI Life Sciences, Inc., a Denver, Colorado-based biotechnology company. (“DMI”). Under the terms of the LOI, if the acquisition is completed, the shareholders of DMI will acquire approximately 90.52% of the total issued and outstanding shares of the Company, and the transaction will constitute a change in control. Completion of the acquisition is subject to the satisfaction of several conditions precedent, including, without limitation, the execution of a definitive merger agreement, the satisfactory completion of due diligence by both parties, the completion of audited financial statements by DMI, and compliance with federal and state securities laws. There can be no assurance that the transaction will be consummated.

    “Gaining access to the public markets will enable us to achieve our goals much sooner, and give our shareholders the value and liquidity they deserve. With a large and diverse portfolio, DMI is well positioned to move into the public market place.”
    DMI is commercializing a patent portfolio covering over 150 drug compounds discovered by its Chief Scientific Officer, David Bar-Or, MD. Dr. Bar-Or, who has been engaged in the discovery and development of medical products for over 20 years, is currently the Director of Trauma Research at Swedish Medical Center and St. Anthony's Hospital both located in Denver. DMI’s three lead products relate to diabetic health care, inflammatory disorders and aging.

    “I have spent my life searching for solutions to major unmet medical conditions that are affordable, proven safe, and simplify the long, expensive and arduous regulatory process that stifles most discoveries,” said Dr. Bar-Or.

    Don Wingerter, DMI’s Chief Executive Officer, an experienced medical products entrepreneur who founded Clear Vision Laser Centers and served as CEO of Sound Surgical Technologies, added, “Gaining access to the public markets will enable us to achieve our goals much sooner, and give our shareholders the value and liquidity they deserve. With a large and diverse portfolio, DMI is well positioned to move into the public market place.”

    Mr. Gregory Bloom, President of Imagine, stated, “We are extremely excited about the possibility of acquiring DMI and bringing its significant opportunities to our shareholders.”

    If the acquisition is consummated, of which there can be no assurance, it is expected that the Company will continue to trade on the NASD OTC BB, under the symbol BTWO.

    About DMI Life Sciences, Inc.

    DMI Life Sciences is a Denver-based biotechnology firm. With several hundred discoveries, high-quality research capabilities and access to extensive clinical data, DMI is developing exciting pharmaceutical products and medical devices.

    SAFE HARBOR STATEMENT

    Certain of the above statements contained in this press release are forward-looking statements that involve a number of risks and uncertainties. Such forward-looking statements are within the meaning of that term in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Readers are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those indicated in the forward-looking statements as a result of various factors.

    Contacts
    Imagine Media, Ltd.
    Gregory Bloom, President
    303-813-1098

     

    (来源: Imagine Media )


    全年征稿 / 资讯合作

    联系邮箱:[email protected]

    版权与免责声明

    • 凡本网注明“来源:来宝网”的所有作品,版权均属于来宝网,转载请必须注明来宝网, http://www.67994619.com,违反者本网将追究相关法律责任。
    • 本网转载并注明自其它来源的作品,目的在于传递更多信息,并不代表本网赞同其观点或证实其内容的真实性,不承担此类作品侵权行为的直接责任及连带责任。其他媒体、网站或个人从本网转载时,必须保留本网注明的作品来源,并自负版权等法律责任。
    • 如涉及作品内容、版权?#20219;?#39064;,请在作品发表之日起一周内与本网联系,否则视为?#29260;?#30456;关权利。


    云南11选5技巧
  • <div id="y09gn"></div>
  • <li id="y09gn"></li>
    <dl id="y09gn"></dl>
    <div id="y09gn"><s id="y09gn"></s></div>
  • <div id="y09gn"></div>
  • <li id="y09gn"></li>
    <dl id="y09gn"></dl>
    <div id="y09gn"><s id="y09gn"></s></div>
    幸运8下载 3d开机号今天彩宝网 江西快三开奖今天走势 上海天天彩开奖结果查询 54张扑克牌单张素材 福彩3d胆拖中奖规则 12134期6场半全场 广东彩票官网 盈利多彩票下载 四川体育彩票走势图 二八杠分析仪下栽 香港六合彩五行表 快乐12开奖号码 爱彩票软件下载 11选5百分百绝杀一码